Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. (Q46016026)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. |
scientific article published in May 2009 |
Statements
1 reference
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. (English)
1 reference
Edith A Perez
1 reference
Adam M Brufsky
1 reference
Linda D Bosserman
1 reference
Richard R Caradonna
1 reference
Barbara B Haley
1 reference
C Michael Jones
1 reference
Halle C F Moore
1 reference
Lixian Jin
1 reference
Ghulam M Warsi
1 reference
Solveig G Ericson
1 reference
1 May 2009
1 reference
1 reference
9
1 reference
2
1 reference
77-85
1 reference
Identifiers
1 reference
1 reference